Med-Tech Innovation July 25, 2024
Oliver Johnson

Cresset, a provider of integrated in silicosolutions for drug discovery has announced the release of V9 – the latest version of its Flare platform for ligand-based and structure-based design, which includes a full integration of Spark, the company’s bioisostere replacement solution.

Flare users will be able to use the range of capabilities brought by this integration to generate ideas for their design projects, while enabling improved efficiencies with custom workflows and task automation via the Flare Python API.

Key Spark features including scaffold hopping and R-group replacement, ligand macrocyclisation, growing and docking, joining two ligands, water replacement and access to the new ‘Linkers’ databases, for linker degrader design, allow even more creativity and streamlining of the small molecule discovery process.

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article